secwatch / observer
8-K filed October 11, 2024, 7:59 PM ET ticker ABUS CIK 0001447028
leadership confidence high sentiment neutral materiality 0.50

CSO Michael J. Sofia to retire Dec 31, 2024; amendment clarifies severance and non-compete

Arbutus Biopharma Corp

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael J. Sofia

Chief Scientific Officer
ABUS · Arbutus Biopharma Corp
Effective
2024-12-31
Filed
October 11, 2024, 7:59 PM ET
As previously disclosed, Michael J. Sofia announced his retirement as Chief Scientific Officer of Arbutus Biopharma, Inc. (the “Company”), a subsidiary of Arbutus Biopharma Corporation, effective December 31, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Michael J. Sofia retired as Chief Scientific Officer at Arbutus Biopharma Corp.

Action
retired
Role
Chief Scientific Officer
Exact text from the filing
As previously disclosed, Michael J. Sofia announced his retirement as Chief Scientific Officer of Arbutus Biopharma, Inc. (the “Company”), a subsidiary of Arbutus Biopharma Corporation, effective December 31, 2024.
View on SEC.gov

Arbutus Biopharma Corp filing history →

Source: SEC EDGAR
accession 0001447028-24-000084
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.